-
Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens
Source: Buzz FX / 02 Jan 2025 09:51:14 America/New_York
Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Blueprint Medicines ( NASDAQ:BPMC - Get Free Report ) 's stock had its "overweight" rating restated b
Read more...